Transcription of MDRO: Prevention in 7 Steps
{{id}} {{{paragraph}}}
MDRO: Prevention in 7 StepsJeanette Harris MS, MSM, MT(ASCP), CICM ultiCare Health SystemTacoma, Drug Resistant OrganismMDROMDRO: What are we talking about? MRSA VRE ESBL ( , Klebs pneum, Pseudo) Acinetobacter sp. Pseudomonas sp. Stenotrophomonas sp. KPC (Klebsiella pn. And others) Etc (and more just waiting) mdro Pseudomonas CEFEPIME R CEFTAZIDIME R CIPROFLOXACIN R GENTAMICIN R IMIPEN/CILASTATIN S PIPERACILLIN/TAZO R TOBRAMYCIN R TRIMETH/SULFA RStaying up at night? mdro Pseudomonas CEFEPIME R CEFTAZIDIME R CIPROFLOXACIN R GENTAMICINS IMIPEN/CILASTATIN R PIPERACILLIN/TAZOR TOBRAMYCIN S TRIMETH/SULFARN ightmares! mdro Acinetobacter CEFEPIME R CEFTAZIDIME R CIPROFLOXACIN R GENTAMICIN R IMIPEN/CILAST R PIP/TAZO R TOBRAMYCIN R TRIMETH/SULFA SDo I have your attention?
MDRO: Prevention in 7 Steps Jeanette Harris MS, MSM, MT(ASCP), CIC MultiCare Health System Tacoma, Wa.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Prevention of Multi-Drug Resistant Organisms, Prevention of Multi-Drug Resistant Organisms MDRO, PREVENTION, MDRO Prevention, Infection Prevention and Control in Dialysis, INFECTION PREVENTION AND CONTROL IN, Methicillin-Resistant Staphylococcus aureus, INTER-FACILITY INFECTION CONTROL TRANSFER, Inter-facility Infection Control, HAI for BOT 02-11-08, Management of Carbapenem-Resistant Enterobacteriaceae (CRE) in, National Quality Forum, Risk Assessment Practice, Risk assessment practice sessions – long term